Filing Details
- Accession Number:
- 0001572426-16-000162
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-01 14:00:26
- Reporting Period:
- 2016-02-25
- Filing Date:
- 2016-03-01
- Accepted Time:
- 2016-03-01 14:00:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1618561 | Nexvet Biopharma Plc | NVET | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632481 | David Gearing | C/O Nexvet Biopharma Plc Unit 5, Sragh Technology Park, Rahan Rd Tullamore L2 R35 FR98 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2016-02-25 | 19,000 | $3.30 | 102,664 | No | 4 | P | Indirect | By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> |
Ordinary Shares | Acquisiton | 2016-02-26 | 12,126 | $3.34 | 114,790 | No | 4 | P | Indirect | By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> |
No | 4 | P | Indirect | By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 279,330 | Indirect | By Gearing Family Pty Ltd <Gearing FamilyA/C> |
Ordinary Shares | 5,600 | Direct |
Footnotes
- The reporting person and his spouse have shared voting and dispositive power with respect to these reported securities.
- Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.35, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.